Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2007
10/17/2007EP1313717B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007EP1141728B1 Kidney disease detection and treatment
10/17/2007EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
10/17/2007CN101056879A Purine derivatives as A3 and A1 adenosine receptor agonists
10/17/2007CN101056875A Substituted phenylaminothiazoles and use thereof
10/17/2007CN101056872A Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
10/17/2007CN101054400A Novel Panoxadiol and derivative, preparation method and medical use thereof
10/17/2007CN101054346A Preparation method and use for a set of novel compound and composition thereof
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053641A Baoyuan kidney-invigorating navel plaster
10/17/2007CN101053632A Traditional Chinese medicine for treating thromboangitis obliterans
10/17/2007CN101053627A Pulse engendendering capsule medicinal composition and its preparation method
10/17/2007CN101053626A Traditional Chinese medicine for treating coronary heart disease and angina pectoris and its preparation method
10/17/2007CN101053607A Blood-nourishing and cephalocathartic micropills and its preparation technology
10/17/2007CN101053598A Medicinal composition for treating cardio-cerebralvascular diseases and diabetes
10/17/2007CN101053590A 'Yinzhanxinmai' medicinal composition and its preparing method
10/17/2007CN101053578A Gingko leaf extract injection containing ginkgolide and preparation method thereof
10/17/2007CN101053570A Novel application for apigenin-7-O-beta-D-glucoside-4'-O-alpha-L-rhamnoside
10/17/2007CN101053563A Zofenopril oral medicinal composition
10/17/2007CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
10/17/2007CN101053557A Noradrenaline bitartrate medicine composition frozen dried powder injection
10/17/2007CN101053556A Water soluble coenzyme Q10 hydroxyl-beta-cyclodextrin inclusion compound and its preparation method
10/17/2007CN101053554A Ginkgolide B powder injection and its preparation method
10/17/2007CN101053438A Health care beverage
10/17/2007CN101053405A Sterile medlar buds lowering blood pressure beverage and food
10/17/2007CN101053395A Edible nutritive health product for heart-dioscorea pig heart
10/17/2007CN101053382A Sichun fritillary bulb wax gourd moon cake
10/17/2007CN101053362A Rhodiola chewing gum and its preparation method
10/17/2007CN101053359A Raspberry health care tea
10/17/2007CN101053354A Producing technology for natural pine needle tea
10/17/2007CN101053350A Compound and processing technology of prolonging life tea having lower blood pressure, blood fat and hypoglycemic effects
10/17/2007CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007CN100343257C CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease
10/17/2007CN100343255C Pyrazolo (1,5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/17/2007CN100343229C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha
10/17/2007CN100342912C Sustained release composition for oral administration of drugs
10/17/2007CN100342891C Medicine composition for hypertension and its preparation thereof
10/17/2007CN100342887C Xinshu capsule
10/17/2007CN100342875C Chinese medicinal capsule for treating piles and its preparing process
10/17/2007CN100342864C Medicine for treating chronic hemorrhoids
10/17/2007CN100342858C Application of yam total saponin in the process for preparing anti-aspirin resisting medicine
10/16/2007USRE39888 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282481 Improved thermostability, acid resistance, alkali resistance, resistance to proteolytic enzymes, and DNA synthesis promoting activity
10/16/2007US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening
10/16/2007US7282222 Methods and compositions for directing cells to target organs
10/16/2007US7282206 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
10/16/2007US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/16/2007CA2272584C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
10/16/2007CA2114250C Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases
10/11/2007WO2007114791A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007113748A1 Oral formulation with beneficial cardiovascular effects, comprising berberine
10/11/2007WO2007113680A2 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
10/11/2007WO2007113368A1 Use of hexapeptides for preparing angiotensin 1 converting enzyme medicinal products
10/11/2007WO2007113365A1 Dairy-protein-derived peptides with angiotensin 1 converting enzyme inhibitory activity
10/11/2007WO2007112986A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
10/11/2007WO2007112566A1 Compositions and methods for treating atherosclerosis
10/11/2007WO2007098387A3 Antihypertensive therapy
10/11/2007WO2007096072A3 New pyridin-3-amine derivatives
10/11/2007WO2007076522A3 Treatment of peripheral vascular disease using postpartum-derived cells
10/11/2007WO2007056996A3 Hypertension agent containing tribomechanically activated zeolites
10/11/2007WO2007030580A3 Neuroprotectants
10/11/2007WO2007017505A3 Treatment of metabolic diseases
10/11/2007WO2006118914A3 Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition
10/11/2007WO2006094763A8 3,4,5-substituted piperidine compounds
10/11/2007WO2006064277A8 Silicon compounds and their use
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238875 Heterocyclic compounds
10/11/2007US20070238869 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238774 Carvedilol dihydrogen phosphate dihydrate; crystal structure; x-ray patterns; mixed venous/arterial vasodilation; non-cardioselective, beta-adrenergic blocking agents; hypotensive agents, congestive heart failure; angina;water solubility; stability; prolonged G.I. bioavailabilty in pH regions
10/11/2007US20070238768 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238766 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238757 Novel treatment
10/11/2007US20070238747 Rifamycin analogs and uses thereof
10/11/2007US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238729 Dna-pk inhibitors
10/11/2007US20070238696 Dosage unit for cardioprotection
10/11/2007US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007US20070238671 Isopeptide Gap Junction Modulators
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007US20070237823 Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
10/11/2007US20070237751 Human Cord Blood as a Source of Neural Tissue Repair of the Brain and Spinal Cord
1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 1595